Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Saturday, November 14, 2026 inter alia; 1. ....

REF. NO.: LASA/SE/25-26/25 Saturday, November 14, 2026 To, To, Corporate Services Department Corporate Services Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block Bandra-Kurla Complex, Mumbai – 400 001. Bandra (E), Mumbai – 400 051. BSE CODE –540702 NSE CODE: LASA Sub: Board Meeting Intimation Dear Sir/Madam, Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Saturday, November 14, 2026 inter alia; 1. To consider, approve and take on records unaudited financial results of the Company for the quarter and half year ended September 30, 2026, along with the Limited Review Report issued by the Statutory Auditor of the Company. 2. To discuss any other matter with the permission of the Chairperson. In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company’s Code of Conduct, the Trading Window shall continue to remain closed till 48 hours after the declaration of the unaudited financial results of the Company for the quarter and half year ended September 30, 2026. This Intimation is also available on the company’s website at www.lasalabs.com and on the website of the stock Exchange at www.bseindia.com and www.nseindia.com . Thanking you. Yours faithfully FOR LASA SUPERGENERICS LIMITED OMKAR HERLEKAR CHAIRMAN AND MANAGING DIRECTOR 01587154